Bristol-Myers Squibb Provides Update on Part 2 of CheckMate -227 - Argus Press

Bristol-Myers Squibb Provides Update on Part 2 of CheckMate -227  Argus Press

PRINCETON, N.J.--(BUSINESS WIRE)--Jul 24, 2019--. Bristol-Myers Squibb Company (NYSE: BMY) today announced that Part 2 of the Phase 3 CheckMate ...